MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial

BACKGROUND AND PURPOSE: Treatments to facilitate recovery after traumatic brain injury (TBI) are urgently needed. We conducted a 9‐month pilot, randomized placebo‐controlled clinical trial to examine the safety and potential effects of the herbal supplement MLC901 (NeuroAiD II™) on cognitive functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Theadom, A., Barker‐Collo, S., Jones, K. M., Parmar, P., Bhattacharjee, R., Feigin, V. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055867/
https://www.ncbi.nlm.nih.gov/pubmed/29611892
http://dx.doi.org/10.1111/ene.13653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055867/
https://www.ncbi.nlm.nih.gov/pubmed/29611892
http://dx.doi.org/10.1111/ene.13653

Ejemplares similares